CRYPTOCOCCUS NEOFORMANS - ANVISA Registration 81504790240
Access comprehensive regulatory information for CRYPTOCOCCUS NEOFORMANS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81504790240 and manufactured by IMMY INC. The registration is held by PASSROD IMPORTAÇÃO E EXPORTAÇÃO DE PRODUTOS PARA SAÚDE LTDA - ME with validity until Oct 13, 2030.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including REMEL INC, BIOSYNEX S.A., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Related Devices (2)
Registration Details
81504790240
25351544470201940
26185222000110
Company Information
Dates and Status
Oct 13, 2020
13/10/2030
09/18/2025 19:00:01
CRYPTOCOCCUS NEOFORMANS
FASTLINE CRYPTOCOCCUS Ag
KHAYROS DIAGNOSTICA FABRICACAO, COMERCIALIZACAO E DISTRIBUICAO DE PRODUTOS LTDA
80105220179
Mar 11, 2024
CRYPTOCOCCUS NEOFORMANS
Crypto Ag ECO Teste
Eco Diagnostica Ltda
80954880175
Aug 16, 2021
CRYPTOCOCCUS NEOFORMANS
Biosynex® CryptoPS
Not specified
80686360294
Aug 17, 2020
CRYPTOCOCCUS NEOFORMANS
Biosynex® CryptoPS
BIOSYNEX S.A.
80686360294
Aug 17, 2020
CRYPTOCOCCUS NEOFORMANS
CRYPTOCOCCUS ANTIGEN LATEX TEST
Not specified
80254180243
Apr 24, 2017

